Cougar Biotechnology to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference.LOS ANGELES -- Cougar Biotechnology, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CGRB) today announced that Alan H. Auerbach, Chief Executive Officer and President of Cougar, will present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Wednesday, February 6, at 11:00 a.m. EST EST electroshock therapy. EST abbr. electroshock therapy at the Grand Hyatt Hotel in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . Mr. Auerbach will provide a company overview and update on the status of Cougar's current clinical development programs. Interested investors may access a live audio webcast by visiting the Investor Relations section of the Company's Web site at www.cougarbiotechnology.com. The presentation will be archived on the Web site and available for 14 days. About Cougar Biotechnology Cougar Biotechnology, Inc. is a Los Angeles-based biotechnology company established to in-license and develop clinical stage drugs, with a specific focus on the field of oncology. Cougar's oncology portfolio includes CB7630, a targeted inhibitor of the 17-alpha hydroxylase/c17,20 lyase lyase /ly·ase/ (li´as) any of a class of enzymes that remove groups from their substrates (other than by hydrolysis or oxidation), leaving double bonds, or that conversely add groups to double bonds. enzyme, which is currently being tested in Phase II clinical trials in prostate cancer; CB3304, an inhibitor of microtubule microtubule Tubular structure enclosed by a membrane found within animal and plant cells. Of varying length, they have several functions. They help give shape to many cells and are major components of cilia and flagella, participate in the formation of the spindle during dynamics, which is currently in a Phase I trial in multiple myeloma and CB1089, an analog of vitamin D, which has been clinically tested in a number of solid tumor types. Further information about Cougar Biotechnology can be found at www.cougarbiotechnology.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion